In this study, tissue reactions and possible toxicological responses of two different bioactive and degradable composite materials consisting of poly( ∈-caprolactone-co-DL-lactide) and bioactive glass (S53P4) granules were evaluated. The chosen materials were implanted subcutaneously in the back of rats for six months. The glass granules retained their bioactivity within the polymer matrices. A fibrous capsule formed around all tested materials and around the materials containing bioactive glass the fibrous capsules appeared to be thicker. Tissue growth into these materials was observed during the healing period while no growth was noticed into the plain polymer matrices. No adverse reactions were seen with any of the evaluated materials.
Rossini, A.A. , Greiner, D.L. , and Mordes, J.P. (1999). Induction of immunologic tolerance for transplantation . Physiol. Rev., 79(1): 99—141 . (b) Chiellini, F. (2006). Perspectives on in vitro evaluation of biomedical polymers . J. Bioact. Comp. Polym., 21: 257—271 .
2.
Böstman, O. and Pihlajamäki, H. (2000). Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review . Biomaterials, 21: 2615—2621 .
3.
Vert, M. , Christel, P. , Chabot, F. , and Leray, J. (1984). Bioresorbable plastic materials for bone surgery . In: Mastings, G.W. , Dycheyne, P. , eds. Macromolecular Biomaterials , pp. 119—142, CRC Press, Inc., Boca Raton, FL .
4.
Hench, L.L. and Paschall, H.A. (1974). Histochemical responses at a biomaterials interface . J. Biomed. Mater. Res., 8(3): 49—64 .
5.
Schepers, E.J. and Ducheyne, P. (1997). Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1—24 month experiment with several materials and particle sizes and size ranges . J. Oral Rehabi., 24(3): 171—181 .
6.
Furusawa, T. and Mizunuma, K. (1997). Osteoconductive properties and efficacy of resorbable bioactive glass as a bone-grafting material . Implant Dent.,6: 93—101 .
7.
Andersson, Ö.H. and Kangasniemi, I. (1991). Calcium phosphate formation at the surface of bioactive glass in vitro . J. Biomed. Mater. Res., 25: 1019—1030 .
8.
Peltola, M. , Suonpää,J. , Aitasalo, K. , Vapula, M. , Yli-Urpo, A. , and Happonen, R.-P. (1998). Obliteration of the frontal sinus cavity with bioactive glass . Head Neck, 20: 315—319 .
9.
Aitasalo, K. , Kinnunen, I. , Palmgren , J. , and Varpula, M. (2001). Repair of orbital floor fractures with bioactive glass implants . J. Oral Maxillofac. Surg., 59: 1390—1395 .
10.
Stoor, P. , Söderling, E. , and Grénman, R. (1999). Interactions between the bioactive glass and the S53P4 and the atrophic rhinitis-associated microorganism Klebsiella ozaenae . J. Biomed. Mater. Res. Appl. Biomater., 48: 869—874 .
11.
Gatti, A.M. , Valdré, G. , and Andersson, Ö.H. (1994 ). Analysis of the in vivo reactions of a bioactive glass in soft and hard tissue . Biomaterials, 15(3): 208—212 .
12.
Stoor, P. , Söderling, E. , Andersson, Ö.H. , and Yli-Urpo, A. (1995). Interactions between the frontal sinusitis-associated pathogen Haemophilus influenzae and the bioactive glass S53P4 . In: 8th International Symposium of Ceramics in Medicine, pp. 253—258, Elsevier Science, Ponte Verde, Oxford, USA.
13.
Woodward, S.C. , Brewer, P.S. , Moatamed , F. , Schindler, A. , and Pitt, C.G. (1985). The intracellular degradation of poly(ε-caprolactone) . J. Biomed. Mater. Res., 19: 437—444 .
14.
Domb, J.A. , Kumar, N. , Sheskin, T. , Bentolila, A. , Slager, J. , and Teomim, D. (2002). Biodegradable polymers as drug carrier system . In: Dumilriu, S. , eds. Polymeric Biomaterials, 2nd edn, pp. 91—121, Marcel Dekker Inc., New York .
15.
Pitt, C.G. , Jeffcoat, A.R. , Zweidinger, R.A. , and Schindler, A. (1979). Sustained drug delivery systems. I. The permeability of poly(∈-caprolactone), poly(DL-lactic acid), and their copolymers . J. Biomed. Mater. Res., 13: 497—507 .
16.
Ozawa, T. , Mickle, D. , Weisel, R.D. , Koyama, N. , Ozawa, S. , and Li, R. (2002). Optimal biomaterial for creation of autologous cardiac grafts . Circulation, 106(12 Suppl. I): 176—182 .
17.
den Dunnen, W.F.A. , Stokroos, I. , Blaauw , E.H. , Holwerda, A. , Pennings, A.J. , Robinson, P.H. , and Schakenraad , J.M. (1996a). Light-microscopic and electron-microscopic evaluation of short-term nerve regeneration using a biodegradable poly(DL-lactide-ε-caprolactone) nerve guide . J. Biomed. Mater. Res., 31: 105—115 .
18.
Nordström, P. , Pihlajamäki, H. , Toivonen , T. , Törmälä, P. , and Rokkanen, P. (1998). Tissue response to polyglycolide and polylactide pins in cancellous bone . Arch. Orthoped. Trauma Surg., 117: 197—204 .
19.
Närhi, T.O. , Jansen, J. , Jaakkola , T. , de Ruijter, A. , Rich, J. , Seppälä, J. , and Yli-Urpo, A. (2003) Bone response to degradable thermoplastic composite in rabbits . Biomaterials, 24: 1697—1704 .
20.
Rich, J. , Jaakkola, T. , Tirri, T. , Närhi, T.O. , Yli-Urpo, A. , and Seppälä, J. (2002). In vitro evaluation of poly(ε-caprolactone-co-DL-lactide)/bioactive glass composites . Biomaterials, 23: 2143—2150 .
21.
Pitt, C.G. , Chaslow, F.I. , Hibionada, Y.M. , Klimas, D.M. , and Schindler, A. (1981). Aliphatic polyesters. I. The degradation of poly(ε-caprolactone) in vivo . J. Appl. Polym. Sci., 26: 3779—3787 .
22.
Pitt, C.G. , Gratzl, M.M. , Kimmel, G.L. , Surles, J. , and Schindler, A. (1981). Aliphatic polyesters II. The degradation of poly(DL-lactide), poly (∈-caprolactone), and their copolymers in vivo . Biomaterials , 2: 215—220 .
23.
Ekholm, M. , Hietanen, J. , Lindqvist, C. , Rautavuori, J. , Santavirta, S. , and Suuronen, R. (1999). Histological study of tissue reactions to ∈-caprolactone-lactide copolymer in paste form . Biomaterials, 20: 1257—1262 .
24.
Holland, S.J. , Tighe, B.J. , and Gould, P.L. (1986). Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. Review . J. Control. Release, 4: 155—180 .
25.
Qiu, Q.-Q. , Ducheyne, P. , and Ayyaswamy, P.S. (2000). New bioactive, degradable composite microspheres as tissue engineering substrates . J. Biomed. Mater. Res., 52(1): 66—76 .
26.
Jaakkola, T. , Rich, J. , Tirri , T. , Närhi, T.O. , Jokinen, M. , Seppälä, J. , and Yli-Urpo, A. (2004). In vitro Ca—P precipitation on biodegradable thermoplastic composite of poly(ε-caprolactone-co-DL-lactide) and bioactive glass (S53P4) . Biomaterials, 25: 575—581 .
27.
den Dunnen, W.F.A. , Robinson, P.H. , van Wessel, R. , Pennings, A.J. , van Leeuwen, M.B.M. , and Schakenraad , J.M. (1996b). Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(DL-lactide-ε-caprolactone) . J. Biomed. Mater. Res., 36: 337—346 .
28.
Andersson, Ö.H. , Vähätalo, K. , Yli-Urpo , A. , Happonen, R.-P. , and Karlsson , K.H. (1994). Short-term reaction kinetics of bioactive glass in simulated body fluid and in subcutaneous tissue . Bioceramics , 7: 67—72 .
29.
Marone, G. , Casolaro, V. , Patella, V. , Florio, G. , and Triggiani, M. (1997). Molecular and cellular biology of mast cells and basophils . Int. Arch. Allergy Immunol., 114(3): 207—217 .
30.
Ali, S.A.M. , Doherty, P.J. , and Williams, D.F. (1994). Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo . Biomaterials, 15(10): 779—785 .
